Advertisement

Topics

First-in-man Sirolimus-eluting Prolim® Stent Registry

2015-09-14 03:14:31 | BioPortfolio

Published on BioPortfolio: 2015-09-14T03:14:31-0400

Clinical Trials [2375 Associated Clinical Trials listed on BioPortfolio]

The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

1500 eligible patients will be treated with the commercially available CYPHER® sirolimus-eluting Bx Velocity™ stent. Patients will be followed to twelve months post-procedure, watching...

BioFreedom QCA Study in CAD Patients

This study aims to demonstrate that the BioFreedom™ Cobalt Chromium Drug Coated Stent is non-inferior to the market authorized BioFreedom™ Stainless Steel Stent with respective to effi...

Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions

The purpose of this study is to evaluate the safety and effectiveness of the Conor Sirolimus-eluting Coronary Stent System in the treatment of coronary artery disease (a single atheroscler...

Occlusal Bite Force Changes After Placement of Stainless Steel Crowns in Children

The aim of this study was to determine if restoring primary molars with SSCs would improve children's OBF.

Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery Lesions

The main objective of this study is to assess the safety and effectiveness of the sirolimus-eluting Bx VELOCITYTM stent in reducing in-lesion restenosis in patients with de novo native cor...

PubMed Articles [2599 Associated PubMed Articles listed on BioPortfolio]

Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention.

Use of the everolimus-eluting stent (EES) instead of the sirolimus-eluting stent (SES) has been shown to improve clinical outcomes in patients undergoing percutaneous coronary intervention (PCI) out t...

Biocompatible Meshes with Appropriate Wettabilities for Underwater-Oil Transportation/Collection and Highly Effective Oil/Water Separation.

In this study we prepared biocompatible superhydrophilic and underwater superoleophobic tannic acid (TA)/polyvinylpyrrolidone (PVP)-modified stainless-steel meshes that mediated extremely efficient se...

Repeat stent implementation for recanalization of the proximal right coronary artery: a case report.

A stent in a false lumen is a common cause of stent occlusion after coronary percutaneous coronary artery intervention therapy, particularly in the culprit lesion of acute myocardial infarction. Here,...

Data on environmental sustainable corrosion inhibitor for stainless steel in aggressive environment.

This data article contains data related to the research article entitled "enhanced corrosion resistance of stainless steel Type 316 in sulphuric acid solution using eco-friendly waste product" (Sanni ...

Pulsed electric fields reduce bacterial attachment to stainless steel plates.

The purpose of this study was to evaluate the capacity of pulsed bilateral electric fields to control bacterial attachment on stainless steel plates. Previously sterilized circular metal plates of sta...

Medical and Biotech [MESH] Definitions

Stainless steel. A steel containing Ni, Cr, or both. It does not tarnish on exposure and is used in corrosive environments. (Grant & Hack's Chemical Dictionary, 5th ed)

An implant used to replace one or more of the ear ossicles. They are usually made of plastic, Gelfoam, ceramic, or stainless steel.

Wires of various dimensions and grades made of stainless steel or precious metal. They are used in orthodontic treatment.

Implants used in arthroscopic surgery and other orthopedic procedures to attach soft tissue to bone. One end of a suture is tied to soft tissue and the other end to the implant. The anchors are made of a variety of materials including titanium, stainless steel, or absorbable polymers.

Abnormal balloon- or sac-like dilatation in the wall of CORONARY VESSELS. Most coronary aneurysms are due to CORONARY ATHEROSCLEROSIS, and the rest are due to inflammatory diseases, such as KAWASAKI DISEASE.

More From BioPortfolio on "First-in-man Sirolimus-eluting Prolim® Stent Registry"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial